Cambridge Investment Research Advisors’s National Health Investors NHI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $532K | Sell |
6,982
-2,214
| -24% | -$170K | ﹤0.01% | 2901 |
|
|
2026
Q1 | $744K | Buy |
9,196
+201
| +2% | +$16.7K | ﹤0.01% | 2434 |
|
|
2025
Q4 | $687K | Buy |
8,995
+139
| +2% | +$10.7K | ﹤0.01% | 2429 |
|
|
2025
Q3 | $704K | Buy |
8,856
+336
| +4% | +$25.1K | ﹤0.01% | 2343 |
|
|
2025
Q2 | $597K | Buy |
8,520
+1,159
| +16% | +$84.9K | ﹤0.01% | 2382 |
|
|
2025
Q1 | $544K | Sell |
7,361
-565
| -7% | -$39.8K | ﹤0.01% | 2358 |
|
|
2024
Q4 | $549K | Sell |
7,926
-830
| -9% | -$63.1K | ﹤0.01% | 2351 |
|
|
2024
Q3 | $736K | Sell |
8,756
-505
| -5% | -$38.9K | ﹤0.01% | 2099 |
|
|
2024
Q2 | $627K | Sell |
9,261
-426
| -4% | -$27.3K | ﹤0.01% | 2110 |
|
|
2024
Q1 | $609K | Buy |
9,687
+2,227
| +30% | +$126K | ﹤0.01% | 2106 |
|
|
2023
Q4 | $417K | Buy |
7,460
+447
| +6% | +$23.7K | ﹤0.01% | 2340 |
|
|
2023
Q3 | $360K | Sell |
7,013
-336
| -5% | -$17.6K | ﹤0.01% | 2361 |
|
|
2023
Q2 | $385K | Sell |
7,349
-516
| -7% | -$26.6K | ﹤0.01% | 2334 |
|
|
2023
Q1 | $406K | Buy |
7,865
+243
| +3% | +$13.3K | ﹤0.01% | 2243 |
|
|
2022
Q4 | $398K | Sell |
7,622
-564
| -7% | -$30.9K | ﹤0.01% | 2204 |
|
|
2022
Q3 | $463K | Buy |
8,186
+341
| +4% | +$21.5K | ﹤0.01% | 1996 |
|
|
2022
Q2 | $476K | Buy |
7,845
+229
| +3% | +$13K | ﹤0.01% | 2001 |
|
|
2022
Q1 | $449K | Buy |
7,616
+13
| +0.2% | +$740 | ﹤0.01% | 2200 |
|
|
2021
Q4 | $437K | Buy |
7,603
+789
| +12% | +$43.7K | ﹤0.01% | 2218 |
|
|
2021
Q3 | $365K | Sell |
6,814
-463
| -6% | -$28.9K | ﹤0.01% | 2294 |
|
|
2021
Q2 | $488K | Sell |
7,277
-902
| -11% | -$62.9K | ﹤0.01% | 2082 |
|
|
2021
Q1 | $591K | Buy |
8,179
+778
| +11% | +$54.3K | ﹤0.01% | 1778 |
|
|
2020
Q4 | $512K | Sell |
7,401
-422
| -5% | -$26.8K | ﹤0.01% | 1757 |
|
|
2020
Q3 | $472K | Sell |
7,823
-1,282
| -14% | -$79.1K | ﹤0.01% | 1641 |
|
|
2020
Q2 | $553K | Sell |
9,105
-1,166
| -11% | -$64.1K | ﹤0.01% | 1496 |
|
|
2020
Q1 | $509K | Buy |
10,271
+1,739
| +20% | +$132K | ﹤0.01% | 1357 |
|
|
2019
Q4 | $695K | Buy |
8,532
+286
| +3% | +$23.4K | 0.01% | 1361 |
|
|
2019
Q3 | $679K | Sell |
8,246
-306
| -4% | -$24.9K | 0.01% | 1301 |
|
|
2019
Q2 | $667K | Buy |
8,552
+605
| +8% | +$47K | 0.01% | 1257 |
|
|
2019
Q1 | $624K | Buy |
7,947
+507
| +7% | +$40.3K | 0.01% | 1334 |
|
|
2018
Q4 | $562K | Buy |
7,440
+50
| +0.7% | +$3.77K | 0.01% | 1245 |
|
|
2018
Q3 | $559K | Buy |
7,390
+1,395
| +23% | +$107K | 0.01% | 1375 |
|
|
2018
Q2 | $442K | Sell |
5,995
-119
| -2% | -$8.41K | ﹤0.01% | 1469 |
|
|
2018
Q1 | $411K | Sell |
6,114
-595
| -9% | -$40.7K | ﹤0.01% | 1451 |
|
|
2017
Q4 | $506K | Buy |
6,709
+666
| +11% | +$51.7K | 0.01% | 1319 |
|
|
2017
Q3 | $467K | Buy |
6,043
+238
| +4% | +$18.6K | 0.01% | 1280 |
|
|
2017
Q2 | $460K | Sell |
5,805
-156
| -3% | -$11.8K | 0.01% | 1252 |
|
|
2017
Q1 | $433K | Buy |
5,961
+365
| +7% | +$26.8K | 0.01% | 1149 |
|
|
2016
Q4 | $415K | Sell |
5,596
-127
| -2% | -$9.32K | 0.01% | 1108 |
|
|
2016
Q3 | $449K | Sell |
5,723
-72
| -1% | -$5.66K | 0.01% | 1096 |
|
|
2016
Q2 | $435K | Buy |
5,795
+623
| +12% | +$43.2K | 0.01% | 997 |
|
|
2016
Q1 | $344K | Buy |
5,172
+706
| +16% | +$43.6K | 0.01% | 1101 |
|
|
2015
Q4 | $272K | Buy |
4,466
+544
| +14% | +$32.4K | 0.01% | 1175 |
|
|
2015
Q3 | $225K | Buy |
3,922
+1
| +0% | +$60 | 0.01% | 1192 |
|
|
2015
Q2 | $244K | Buy |
3,921
+823
| +27% | +$55K | 0.01% | 1163 |
|
|
2015
Q1 | $220K | Buy |
+3,098
| New | +$224K | 0.01% | 1196 |
|
Other funds holding NHI
SIS
WIC
JBC
LDB
COPPSERS
SOADOR
NI
Cambridge Investment Research Advisors's NHI Position: Q2 2026 in Review
Cambridge Investment Research Advisors reduced its National Health Investors (NHI) stake by 24% in Q2 2026, selling an estimated $170K and leaving 6,982 shares worth $532K. The position accounts for ﹤0.01% of the portfolio, ranked #2901.
Cambridge Investment Research Advisors first reported a position in NHI in Q1 2015 and has held it in 46 quarters since. The position peaked at $744K in Q1 2026. 82 funds tracked by Wall St. Rank hold NHI as of Q2 2026.
- Cambridge Investment Research Advisors held 6,982 shares of National Health Investors worth $532K as of Q2 2026.
- Cambridge Investment Research Advisors sold 2,214 National Health Investors shares in Q2 2026, an estimated $170K.
- National Health Investors made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2901 holding.
- Cambridge Investment Research Advisors first reported a position in National Health Investors in Q1 2015 and has held it in 46 quarters since.
- Cambridge Investment Research Advisors's National Health Investors position peaked at $744K in Q1 2026.
- 82 funds tracked by Wall St. Rank held National Health Investors as of Q2 2026.
Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.